Roche defends German Avastin refund plan
26 October 2011
Ian Schofield
Please Login to read the full article.
26 October 2011
Ian Schofield
Please Login to read the full article.
RELATED CONTENT
NEWS
- CATT 2-year results add fuel to Avastin/Lucentis debate, with implications for Eylea
- Novartis/Roche plays cancer card to justify non-development of Avastin in AMD
- US Capitol Capsule: Health reform draws amicus attention, but most Americans 'meh' on impact
- NICE plans appraisal for Pfizer's Inlyta in RCC where others have failed
ANALYSIS
Other Informa Analysis
EVENTS
Today
The Rembrandt Hotel, London
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
